Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Diabetes in Developing Countries
Published in: International Journal of Diabetes in Developing Countries 1/2013

01-03-2013 | Editorial

International Journal of Diabetes in Developing Countries

Author: Hemraj B. Chandalia

Published in: International Journal of Diabetes in Developing Countries | Issue 1/2013

Login to get access

Excerpt

The journal is entering its 33rd eventful year of publication. It is right time to recount the history of this journal, its transformation into a truly international journal and the reasons to stake its rightful claim amongst the diabetology journals. There is also a personal reason for me to undertake this writing as I lay down the office of the Editor-in-Chief after my participation in the editorial process of this journal for the past 22 years. …
Literature
1.
2.
Jain R, Kabadi U, Kabadi M. Hypoglycemic activity of Hemidesmus indicus R. Br. on streptozotocin-induced diabetic rats. Int J Diab Dev Ctries. 2008;28:6–10.CrossRef
3.
Najmi A, Mohammad N, Khan RA, Haque SF. Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome. Int J Diab Dev Ctries. 2008;28:11–4.CrossRef
4.
Andallu B, Kumar AVV, Varadacharyulu NC. Lipid abnormalities in streptozotocin-diabetes: Amelioration by Morus indica L. cv Suguna leaves. Int J Diab Dev Ctries. 2009;29:123–8.CrossRef
5.
Gupta RN, Pareek A, Suthar M, Rathore GS, Basniwal PK, Jain D. Study of glucose uptake activity of Helicteres isora Linn. Fruits in L-6 cell lines. Int J Diab Dev Ctries. 2009;29:170–3.CrossRef
6.
Thakkar NV, Patel JA. Pharmacological evaluation of “Glyoherb”: A polyherbal formulation on streptozotocin-induced diabetic rats. Int J Diab Dev Ctries. 2010;30:1–7.CrossRef
7.
Adiga S, Bairy KL, Meharban A, Punita ISR. Hypoglycemic effect of aqueous extract of Trichosanthes dioica in normal and diabetic rats. Int J Diab Dev Ctries. 2010;30:38–42.CrossRef
8.
Hypoglycemic effect of aqueous extract of Trichosanthes dioica in normal and diabetic rats. Int J Diab Dev Ctries. 2010; 30: 38–42.
9.
Jayakuamar RV. Herbal Medicines for type-2 diabetes. Int J Diab Dev Ctries. 2010;30:111–2.CrossRef
10.
Ezeigbo II. Anti-diabetic potential of methanolic leaf extracts of Icacina trichantha in alloxan-induced diabetic mice. Int J Diab Dev Ctries. 2010;30:150–2.CrossRef
11.
Kumar N, Gupta AK, Prakash D, Kumar P. Hypoglycemic activity of Onosma hispidum (Ratanjot). Int J Diab Dev Ctries. 2010;30:213–6.CrossRef
12.
Ukwe CV, Ubaka CM. Hypoglycemic activity of leaves of Acanthus montanus T. Anderson (Acanthaceae) in rats. Int J Diab Dev Ctries. 2011;31:32–6.CrossRef
13.
Ramudu SK, Mallikarjuna K, Kesireddy SR. Efficacy of ethanolic extract of ginger on kidney lipid metabolic profiles in diabetic rats. Int J Diab Dev Ctries. 2011;31:97–103.CrossRef
14.
Pramanath R, Lakshmidevi N, Jayashree K, Suresh RN. Evaluation of anti-diabetic effect of Trigonella foenum graecum Linn. Leaf extract streptozotocin-induced diabetic rats. Int J Diab Dev Ctries. 2012;32:164–9.
15.
Renjith RS, Rajamohan T. Young influorescence of Cocos nucifera contributes to improvement of glucose homeostasis and antioxidant status in diabetic rats. Int J Diab Dev Ctries. 2012;32:193–8.CrossRef
16.
Bhaskar A, Vidhya VG. Hypoglycemic and hypolipidemic activity of Hibiscus rosa sinensis Linn on streptozotocin-induced diabetic rats. Int J Diab Dev Ctries. 2012;32:214–8.CrossRef
17.
Arun KP, Murugan R, Kanna RM, Rajalakshmi S, Kalaiselvi R, Komathi V. The impact of Pharmaceutical care on the clinical outcome of diabetes mellitus among a rural patient population. Int J Diab Dev Ctries. 2008;28:15–8.CrossRef
18.
Gooneratne IK, Ranaweera AKP, Liyanarachchi NP, Gunawardane N, Lanerolle RD. Epidemiology of chronic kidney disease in a Sri Lankan population. Int J Diab Dev Ctries. 2008;28:60–4.CrossRef
19.
Khatib NM, Quazi ZS, Gaidhane AM, Waghmare TS, Goyal RC. Risk factors of type-2 diabetes mellitus in rural Wardhan: A community based study. Int J Diab Dev Ctries. 2008;28:79–82.CrossRef
20.
Tiwari RR, Deb PK, Debbarma A, Chaudhuri R, Chakraborti A, Lepcha M, Chakraborti G. Risk factor analysis in self-reported diabetes in a rural Kerala population. Int J Diab Dev Ctries. 2008;28:91–4.CrossRef
21.
Sharifi N, Khoshbaten M, Aliasgarzade A, Bahrami A. Celiac disease in patients with type 1 diabetes mellitus screened by tissue transglutaminase antibodies in northwest of Iran. Int J Diab Dev Ctries. 2008;28:95–9.CrossRef
22.
Azevedo M, Alla S. Diabetes in Sub-Saharan Africa: Kenya, Mali, Mozambique, Nigeria, South Africa and Zambia. Int J Diab Dev Ctries. 2008;28:101–8.CrossRef
23.
Purti AJ, Vedapriya DR, Bazroy J, Gupta S, Cherian J, Vishwanathan M. Prevalence of diagnosed diabetes in an urban area of Puducherry, India: Time of preventive action. Int J Diab Dev Ctries. 2009;29:1–5.CrossRef
24.
Avasarala KA, Bachu A. Survey of childhood diabetes and impact of school level educational interventions in rural schools in Karimnagar district. Int J Diab Dev Ctries. 2009;29:69–73.CrossRef
25.
Venkatraman K, Kannan AT, Mohan V. Challenges in diabetes management with particular reference to India. Int J Diab Dev Ctries. 2009;29:103–9.CrossRef
26.
Shah VN, Kamdar PK, Shah N. Assessing the knowledge, attitudes and practice of type 2 diabetes among patients of Saurashtra region. Gujarat Int J Diab Dev Ctries. 2009;29:118–22.CrossRef
27.
Rai M, Kishor J. Myths about diabetes and its treatment in North Indian population. Int J Diab Dev Ctries. 2009;29:129–32.CrossRef
28.
Muninarayana C, Balachandra G, Hiremath SG, Iyengar K, Anil NS. Prevalence and awareness regarding diabetes mellitus in rural Tamaka. Kolar Int J Diab Dev Ctries. 2010;30:18–21.CrossRef
29.
Rao CR, Kamath VG, Shetty A, Kamath A. A study on the prevalence of type 2 diabetes in coastal Karnataka. Int J Diab Dev Ctries. 2010;30:80–5.CrossRef
30.
Mohamud WNW, Suraiami M. Prevalence of diabetes, impaired fasting glucose and metabolic syndrome among female Orang Asli community in Peninsular Malaysia. Int J Diab Dev Ctries. 2010;30:118–22.CrossRef
31.
Mohan V, Deepa M. Prevalence of diabetes and metabolic syndrome among Asians. Int J Diab Dev Ctries. 2010;30:173–5.CrossRef
32.
Chakraborti R, Dey S, DKhar PS, Thabah CR, Rynjah W. Diabetics of Northeast India are at risk of dietary Zinc and Manganese deficiency: Possible improvement through consumption of some traditional edibles or edibles of limited popularity. Int J Diab Dev Ctries. 2010;30:201–7.CrossRef
33.
Sharma R, Grover VL, Chaturvedi S. Recipe for diabetes disaster: a study of dietary behaviors among adolescent students in South Delhi. India Int J Diab Dev Ctries. 2011;31:4–8.CrossRef
34.
Chandalia HB. Will the epidemic of diabetes in India subside? Int J Diab Dev Ctries. 2011;31:45–7.CrossRef
35.
Vuvor F, Steiner-Aseidu M, Armar-Klemesu M, Armah S. Population-based study of diabetic mellitus prevalence and its associated factors in adult Ghanaians in the greater Accra region. Int J Diab Dev Ctries. 2011;31:149–53.CrossRef
36.
Al-Shafaee MA, Bhargava K, Al-Farsi YM, Mcilvenny S, Al-Mandhari A, Al-Adawi S, Manari AA. Prevalence of pre-diabetes and associated risk factors in an adult Omani population. Int J Diab Dev Ctries. 2011;31:161–5.CrossRef
37.
Grover SBS, Kumar S, Bhansali A, Jaggi S. Psychological impact of type-1 diabetes mellitus on parents: an exploratory study from North India. Int J Diab Dev Ctries. 2011;31:174–9.CrossRef
38.
Abdel-Rahim A, Lachine N, Zeitoun M, El-Gendi W. Intensified insulin therapy during fasting of Ramadan type 1 diabetic patients. Int J Diab Dev Ctries. 2011;31:216–22.CrossRef
39.
Alsafar H, Jama-Alol KA, Hassoun AAK, Tay GK. The prevalence of type 2 diabetes mellitus in the United Arab Emirates family registry. Int J Diab Dev Ctries. 2012;32:25–32.CrossRef
40.
Bener A, Yousafzai MT, Al-Hamaq AO. Familial aggregation of T2DM among Arab diabetic population. Int J Diab Dev Ctries. 2012;32:90–2.CrossRef
41.
Nagarathna R, Usharani MR, Rao AR, Chaku R, Kulkarni R, Nagendra HR. Efficacy of yoga-based lifestyle modification program on medication score and lipid profile in type 2 diabetes—a randomized control study. Int J Diab Dev Ctries. 2012;32:90–2.CrossRef
Metadata
Title
International Journal of Diabetes in Developing Countries
Author
Hemraj B. Chandalia
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2013
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-012-0110-2

Other articles of this Issue 1/2013

International Journal of Diabetes in Developing Countries 1/2013 Go to the issue

Original Article

Associations of apolipoprotein A5 with triglyceride, adiponectin and insulin resistance in patients with impaired glucose regulation and type 2 diabetes mellitus

Original Article

Urinary IgG is a pure strong indicator of diabetic nephropathy than microalbuminuria in type 2 diabetic patients

Original Article

Application of community periodontal index of treatment need (CPITN) in a group of insulin dependent diabetes mellitus (IDDM) patients

Original Article

Antidiabetic and antioxidant effect of Swietenia macrophylla seeds in experimental type 2 diabetic rats

Original Article

New estimates of pre-diabetes and type 2 diabetes prevalence in Mexican Quintana Roo

Original Article

An observational study of foot ulceration risk in diabetic patients evaluated with autofluorescence: 195 cases cross-sectional and one-year outcome
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits